IGHMBP2 -related clinical and genetic features in a cohort of Chinese Charcot–Marie–Tooth disease type 2 patients
- 18 November 2016
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 27 (2), 193-199
- https://doi.org/10.1016/j.nmd.2016.11.008
Abstract
No abstract availableKeywords
Funding Information
- Hunan Provincial Innovation Foundation for Postgraduate (CX2015B064)
- State Key Program of National Natural Science Foundation of China (81130021, 81430023)
This publication has 24 references indexed in Scilit:
- Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cellsEuropean Journal of Paediatric Neurology, 2014
- The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1Nucleic Acids Research, 2012
- Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old manNeuromuscular Disorders, 2011
- IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)Human Molecular Genetics, 2009
- Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysisHuman Mutation, 2007
- Structural and functional insights into the human Upf1 helicase coreThe EMBO Journal, 2006
- Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)Human Molecular Genetics, 2004
- Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)Annals of Neurology, 2003
- Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1Nature Genetics, 2001
- DExD/H Box RNA HelicasesMolecular Cell, 2001